As we move through the latter half of 2020, synthetic data has emerged as a promising solution to one of the most pressing issues in AIābalancing innovation with privacy. In the wake of COVID-19, organizations in healthcare, finance, and public policy have raced to deploy AI at scale. However, the urgency of this digital transformation has amplified longstanding data privacy concerns. Enter synthetic data: artificially generated datasets that preserve statistical properties of real data without exposing sensitive information.
What is Synthetic Data?
Synthetic data refers to information generated algorithmically to mimic the properties of real-world datasets. It can be used for training machine learning models, validating systems, and simulating scenarios without the risk of exposing personal or proprietary information. There are generally two types:
Fully Synthetic Data: Created entirely from scratch using statistical models, generative adversarial networks (GANs), or simulation engines.
Partially Synthetic Data: Combines real data with generated components to obscure sensitive features.
Why Now? The COVID-19 Catalyst
The urgency of pandemic-related research in 2020 has accelerated interest in privacy-preserving data methods. With hospitals and labs reluctant to share patient-level data, researchers turned to synthetic alternatives to model virus spread and optimize resource allocation. For example, a collaboration between MIT and the Mayo Clinic used synthetic data to develop COVID-19 patient risk models without exposing actual health records.
Simultaneously, regulatory pressures such as GDPR and HIPAA have heightened scrutiny around data sharing and use, forcing organizations to explore alternative datasets that meet compliance standards while enabling innovation.
Technical Approaches Gaining Traction
October 2020 has seen rapid advancements in methods for generating synthetic data:
-
Generative Adversarial Networks (GANs) remain a primary tool. A notable example is the work by Yale and Anthem Inc., where GANs were used to create privacy-preserving medical datasets.
-
Differential Privacy is increasingly layered into synthetic data pipelines to offer formal privacy guarantees.
-
Bayesian Networks and Agent-Based Models are also being explored for applications like financial fraud detection and epidemiological forecasting.
-
Tools like the Synthetic Data Vault (SDV) from MITās Data to AI Lab have become popular in the open-source community for generating high-quality tabular data.
Applications Across Industries
Healthcare: Synthetic EHRs (electronic health records) are enabling collaboration between institutions without risking patient privacy.
Finance: Banks and fintech firms use synthetic transaction data to test fraud detection algorithms without using sensitive customer records.
Retail & Mobility: Simulated foot traffic and consumer behavior data help businesses model reopening strategies amid ongoing pandemic uncertainties.
Challenges and Ethical Considerations
Despite its potential, synthetic data isnāt without caveats:
Utility vs. Privacy Trade-off: Striking a balance between preserving utility and guaranteeing privacy remains a core challenge.
Bias Reproduction: If the source data is biased, the synthetic version may propagate or even amplify those biases.
Trust and Transparency: Stakeholders must trust the generation process, which often involves opaque deep learning models.
Researchers are actively exploring ways to audit synthetic datasets and measure their fidelity and fairness.
Conclusion
As of October 2020, synthetic data is transitioning from research novelty to enterprise solution. Spurred by pandemic-related urgency and tightening regulatory environments, it is proving to be a valuable bridge between privacy and progress. While technical and ethical challenges remain, the trajectory suggests synthetic data will play a foundational role in the next wave of responsible AI development.
Next in the Series
November 2020: Edge AI: From Cloud-Centric to Real-Time Intelligence at the Edge
References
[1] MIT Critical Data & Mayo Clinic (2020). Using Synthetic Data to Support COVID-19 Risk Models. https://news.mit.edu/2020/synthetic-data-covid19-mayo-clinic-0618
[2] Esteban, C., Hyland, S.L., & RƤtsch, G. (2017). Real-valued (Medical) Time Series Generation with Recurrent Conditional GANs. https://arxiv.org/abs/1706.02633
[3] Patki, N., Wedge, R., & Veeramachaneni, K. (2016). The Synthetic Data Vault. MIT Data to AI Lab. https://sdv.dev
[4] Bellovin, S., et al. (2019). Privacy and Synthetic Datasets. Columbia University. https://datasociety.net/wp-content/uploads/2019/03/DS_Privacy-and-Synthetic-Datasets.pdf